HMGB1 and acute kidney injury: Inflammation is a well-recognized contributor to the development of CI-AKI, and SIRT1 has been shown to exert anti-inflammatory effects through multiple mechanisms, including inhibition of the NF-κB signaling pathway and deacetylation of high-mobility group box 1 (HMGB1) protein [9,10].